IFNAR1 signaling in NK cells promotes persistent virus infection

被引:12
|
作者
Huang, Zhe [1 ]
Kang, Seung Goo [1 ,2 ]
Li, Yunqiao [1 ]
Zak, Jaroslav [1 ]
Shaabani, Namir [1 ]
Deng, Kaiyuan [1 ,3 ]
Shepherd, Jovan [1 ]
Bhargava, Raag [1 ]
Teijaro, John R. [1 ]
Xiao, Changchun [1 ]
机构
[1] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA
[2] Kangwon Natl Univ, Coll Biomed Sci, Dept Mol Biosci, Inst Biosci & Biotechnol, Chunchon, South Korea
[3] Nankai Univ, Sch Med, Tianjin 30071, Peoples R China
关键词
Signaling - Antigens - Viruses - Cell signaling - Cytology - Antibodies - Interferons;
D O I
10.1126/sciadv.abb8087
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Inhibition of type 1 interferon (IFN-I) signaling promotes the control of persistent virus infection, but the underlying mechanisms remain poorly understood. Here, we report that genetic ablation of Ifnar1 specifically in natural killer (NK) cells led to elevated numbers of T follicular helper cells, germinal center B cells, and plasma cells and improved antiviral T cell function, resulting in hastened virus clearance that was comparable to IFNAR1 neutralizing antibody treatment. Antigen-specific B cells and antiviral antibodies were essential for the accelerated control of LCMV Cl13 infection following IFNAR1 blockade. IFNAR1 signaling in NK cells promoted NK cell function and general killing of antigen-specific CD4 and CD8 T cells. Therefore, inhibition of IFN-I signaling in NK cells enhances CD4 and CD8 T cell responses, promotes humoral immune responses, and thereby facilitates the control of persistent virus infection.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] West Nile Virus Infection Induces Depletion of IFNAR1 Protein Levels
    Evans, Jared D.
    Crown, Rachel A.
    Sohn, Ji A.
    Seeger, Christoph
    VIRAL IMMUNOLOGY, 2011, 24 (04) : 253 - 263
  • [2] Phosphorylation-dependent regulation of IFNAR1 stability and signaling
    Fuchs, Serge Y.
    CYTOKINE, 2010, 52 (1-2) : 78 - 78
  • [3] IFNAR1 gene polymorphism associated with chronic hepatitis B virus infection in a Thai population
    Phuengwas, Sudtida
    Hongtrakul, Vipa
    Hirankarn, Nattiya
    Tangkijvanich, Pisit
    Pothiratana, Chetsada
    Kimkong, Ingorn
    SCIENCEASIA, 2015, 41 (01): : 22 - 27
  • [4] IFN-β-specific signaling via a unique IFNAR1 interaction
    Kaur, Surinder
    Platanias, Leonidas C.
    NATURE IMMUNOLOGY, 2013, 14 (09) : 884 - 885
  • [5] IFN-β-specific signaling via a unique IFNAR1 interaction
    Surinder Kaur
    Leonidas C Platanias
    Nature Immunology, 2013, 14 : 884 - 885
  • [6] Conditional IFNAR1 ablation reveals distinct requirements of Type I IFN signaling for NK cell maturation and tumor surveillance
    Mizutani, Tatsuaki
    Neugebauer, Nina
    Putz, Eva M.
    Moritz, Nadine
    Simma, Olivia
    Zebedin-Brandl, Eva
    Gotthardt, Dagmar
    Warsch, Wolfgang
    Eckelhart, Eva
    Kantner, Hans-Peter
    Kalinke, Ulrich
    Lienenklaus, Stefan
    Weiss, Siegfried
    Strobl, Birgit
    Mueller, Mathias
    Sexl, Veronika
    Stoiber, Dagmar
    ONCOIMMUNOLOGY, 2012, 1 (07): : 1027 - 1037
  • [7] Fine structural and functional characterization of a unique IFNβ/Ifnar1 signaling axis
    De Weerd, N.
    Nguyen, T.
    Vivian, J.
    Mangan, N. E.
    Gould, J. A.
    Noppert, S.
    Zaker-Tabrizi, L.
    Beddoe, T.
    Reid, H. H.
    Rossjohn, J.
    Hertzog, P. J.
    CYTOKINE, 2012, 59 (03) : 501 - 501
  • [8] TYK2 activity promotes ligand-induced IFNAR1 proteolysis
    Marijanovic, Zrinka
    Ragimbeau, Josiane
    Kumar, K. G. Suresh
    Fuchs, Serge Y.
    Pellegrini, Sandra
    BIOCHEMICAL JOURNAL, 2006, 397 : 31 - 38
  • [9] IFNAR1 downregulation during melanoma progression upregulates av expression and promotes metastasis
    Ortiz, Angelica
    Katlinskaya, Yuliya V.
    Katlinski, Kanstantsin V.
    Fuchs, Serge Y.
    CANCER RESEARCH, 2016, 76
  • [10] Exhaustive genotyping of the interferon alpha receptor 1 (IFNAR1) gene and association of an IFNAR1 protein variant with AIDS progression or susceptibility to HIV-1 infection in a French AIDS cohort
    Diop, G.
    Hirtzig, T.
    Do, H.
    Coulonges, C.
    Vasilescu, A.
    Labib, T.
    Spadoni, J. -L.
    Therwath, A.
    Lathrop, M.
    Matsuda, F.
    Zagury, J. -F.
    BIOMEDICINE & PHARMACOTHERAPY, 2006, 60 (09) : 569 - 577